Review
World J Pharmacol
3(4):39-55.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.39
Abstract (2045)
|
Core Tip (1774)
|
Full Article (HTML) (16268)
|
Figures (1-3) (465)
|
Tables (1-5) (484)
|
Full Article (PDF)-1451K (1272)
|
Peer-Review Report-94K (399)
|
Answering Reviewers-72K (329)
|
Received: 06/26/2014
|
Revised: 09/09/2014
|
Accepted: 10/10/2014
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (63)
|
Total Visits (29861)
|
Similar Articles (8)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):56-71.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.56
Abstract (2036)
|
Core Tip (1661)
|
Full Article (HTML) (9274)
|
Figures (1-1) (879)
|
Tables (1-3) (419)
|
Full Article (PDF)-1210K (769)
|
Peer-Review Report-98K (339)
|
Answering Reviewers-99K (292)
|
Received: 07/01/2014
|
Revised: 08/01/2014
|
Accepted: 09/17/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (19391)
|
Similar Articles (166)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):72-85.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.72
Abstract (1848)
|
Core Tip (1671)
|
Full Article (HTML) (9863)
|
Figures (1-4) (1335)
|
Tables (1-1) (434)
|
Full Article (PDF)-1374K (1107)
|
Peer-Review Report-105K (333)
|
Answering Reviewers-58K (416)
|
Received: 07/28/2014
|
Revised: 08/29/2014
|
Accepted: 09/24/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (9)
|
Total Visits (20793)
|
Similar Articles (7)
|
Timeline of Article Publication (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):86-96.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.86
Abstract (1697)
|
Core Tip (1643)
|
Full Article (HTML) (7531)
|
Figures (1-3) (557)
|
Full Article (PDF)-2317K (832)
|
Peer-Review Report-102K (336)
|
Answering Reviewers-250K (385)
|
Received: 07/28/2014
|
Revised: 10/01/2014
|
Accepted: 10/29/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (5)
|
Total Visits (16366)
|
Similar Articles (2)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):97-109.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.97
Abstract (1459)
|
Core Tip (1339)
|
Full Article (HTML) (6105)
|
Figures (1-1) (420)
|
Tables (1-4) (430)
|
Full Article (PDF)-1455K (716)
|
Peer-Review Report-129K (214)
|
Answering Reviewers-81K (228)
|
Received: 06/28/2014
|
Revised: 10/02/2014
|
Accepted: 11/10/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (13922)
|
Similar Articles (0)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Harnessing pharmacological knowledge for personalized medicine and pharmacotyping: Challenges and lessons learned

World J Pharmacol
3(4):110-119.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.110
Abstract (1482)
|
Core Tip (1264)
|
Full Article (HTML) (4116)
|
Figures (1-1) (427)
|
Tables (1-1) (396)
|
Full Article (PDF)-2534K (548)
|
Peer-Review Report-98K (268)
|
Answering Reviewers-19K (197)
|
Received: 06/12/2014
|
Revised: 07/03/2014
|
Accepted: 10/29/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (12561)
|
Similar Articles (7)
|
Timeline of Article Publication (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):120-139.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.120
Abstract (1865)
|
Core Tip (1505)
|
Full Article (HTML) (8796)
|
Figures (1-2) (525)
|
Tables (1-1) (358)
|
Full Article (PDF)-1376K (780)
|
Peer-Review Report-116K (442)
|
Answering Reviewers-78K (353)
|
Received: 06/29/2014
|
Revised: 09/01/2014
|
Accepted: 09/24/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (20904)
|
Similar Articles (69)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):140-152.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.140
Abstract (1845)
|
Core Tip (1684)
|
Full Article (HTML) (8178)
|
Figures (1-2) (404)
|
Tables (1-1) (381)
|
Full Article (PDF)-2415K (556)
|
Peer-Review Report-106K (419)
|
Answering Reviewers-72K (309)
|
Received: 06/27/2014
|
Revised: 10/02/2014
|
Accepted: 11/03/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (17)
|
Total Visits (16948)
|
Similar Articles (0)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(1)
|
Open
Minireviews
Pharmacological role of efflux transporters: Clinical implications for medication use during breastfeeding

World J Pharmacol
3(4):153-161.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.153
Abstract (1693)
|
Core Tip (1539)
|
Full Article (HTML) (5756)
|
Figures (1-1) (394)
|
Full Article (PDF)-1040K (590)
|
Peer-Review Report-104K (355)
|
Answering Reviewers-60K (259)
|
Received: 06/28/2014
|
Revised: 09/03/2014
|
Accepted: 09/24/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (6)
|
Total Visits (14082)
|
Similar Articles (10)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):162-173.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.162
Abstract (1714)
|
Core Tip (1745)
|
Full Article (HTML) (7532)
|
Figures (1-2) (445)
|
Tables (1-1) (390)
|
Full Article (PDF)-4747K (830)
|
Peer-Review Report-116K (364)
|
Answering Reviewers-128K (352)
|
Received: 06/27/2014
|
Revised: 08/07/2014
|
Accepted: 10/29/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (6)
|
Total Visits (19780)
|
Similar Articles (2)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):174-185.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.174
Abstract (1400)
|
Core Tip (1164)
|
Full Article (HTML) (4708)
|
Tables (1-1) (425)
|
Full Article (PDF)-1054K (434)
|
Peer-Review Report-106K (313)
|
Answering Reviewers-75K (223)
|
Received: 07/29/2014
|
Revised: 10/02/2014
|
Accepted: 10/27/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (11778)
|
Similar Articles (18)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):186-192.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.186
Abstract (1646)
|
Core Tip (1275)
|
Full Article (HTML) (7350)
|
Tables (1-2) (435)
|
Full Article (PDF)-872K (684)
|
Peer-Review Report-82K (333)
|
Answering Reviewers-100K (283)
|
Received: 05/16/2014
|
Revised: 07/04/2014
|
Accepted: 09/17/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (16489)
|
Similar Articles (31)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Therapeutics Advances
World J Pharmacol
3(4):193-198.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.193
Abstract (1439)
|
Core Tip (1159)
|
Full Article (HTML) (2631)
|
Figures (1-2) (340)
|
Tables (1-1) (361)
|
Full Article (PDF)-1053K (396)
|
Peer-Review Report-98K (345)
|
Answering Reviewers-31K (198)
|
Received: 06/24/2014
|
Revised: 09/22/2014
|
Accepted: 10/10/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (12749)
|
Similar Articles (759)
|
Timeline of Article Publication (2)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Evidence-Based Medicine
World J Pharmacol
3(4):199-208.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.199
Abstract (1651)
|
Core Tip (1474)
|
Full Article (HTML) (7383)
|
Tables (1-4) (524)
|
Full Article (PDF)-1067K (618)
|
Peer-Review Report-118K (314)
|
Answering Reviewers-113K (341)
|
Received: 07/28/2014
|
Revised: 09/08/2014
|
Accepted: 10/16/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (16093)
|
Similar Articles (77)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Systematic Reviews
Association of serum bilirubin and non-alcoholic fatty liver disease: A feasible therapeutic avenue?

World J Pharmacol
3(4):209-216.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.209
Abstract (1694)
|
Core Tip (1378)
|
Full Article (HTML) (9387)
|
Figures (1-1) (407)
|
Tables (1-2) (658)
|
Full Article (PDF)-1014K (500)
|
Peer-Review Report-80K (323)
|
Answering Reviewers-67K (237)
|
Received: 05/21/2014
|
Revised: 07/14/2014
|
Accepted: 10/27/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (18567)
|
Similar Articles (226)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open